Feedback / Questions
pegcantratinib (SNA-120) - Bio3 Research, Sienna
Creabilis: Biotech & Money
(Creabilis)
-
Mar 7, 2015 -
Anticipated NDA filing for pruritic psoriasis in 2017
Anticipated NDA
•
Psoriasis
http://www.creabilis-sa.com/uploads/images/Creabilis%20%20CT327%20Biotech%20%20Money%20Feb%202015%20final.pdf
Mar 7, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.